Wenzhou Kangning Hospital Co., Ltd. (2120.HK)
HKD 12.52
(-0.16%)
HKD 12.52
(-0.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 265.03 Million | 227.22 Million | 193.89 Million | 199.65 Million | 111.28 Million | 66.52 Million |
| Net Income | 85.94 Million | -10.96 Million | 44.04 Million | 58.95 Million | 38.22 Million | 74.96 Million |
| Depreciation & Amortization | 113.55 Million | 114.21 Million | 104.58 Million | 88.25 Million | 75.54 Million | 38.84 Million |
| Deferred income taxes | - | -12.21 Million | -15.93 Million | 31.51 Million | -13 Million | 33.24 Million |
| Stock-based compensation | - | 4.41 Million | 15.93 Million | 5.88 Million | 5.92 Million | 2.37 Million |
| Change in working capital | -37.85 Million | -17.32 Million | -18.74 Million | -47.3 Million | -56.88 Million | -113.63 Million |
| Other non-cash items | 86.64 Million | 141.3 Million | 64 Million | 62.35 Million | 61.49 Million | 30.71 Million |
| Investing Cash Flow | -215.01 Million | -273.61 Million | -239.04 Million | -186.31 Million | -140.53 Million | -155.48 Million |
| Investments in PPE | -179.73 Million | -236.91 Million | -178.53 Million | -187.95 Million | -127.54 Million | -145.49 Million |
| Acquisitions | -31.78 Million | -53.68 Million | -80.56 Million | -24.83 Million | 1.3 Million | -17.52 Million |
| Investment purchases | - | 0.59 | -48.6 Million | -34.54 Million | -48.45 Million | -25.19 Million |
| Sales/Maturities of investments | 8.27 Million | 1.65 Million | 59.89 Million | 49.09 Million | 1.97 Million | - |
| Other Investing Activities | -1.19 Million | 15.32 Million | 8.75 Million | 11.92 Million | 32.18 Million | 32.72 Million |
| Financing Cash Flow | 96.1 Million | 116.17 Million | 33.83 Million | 22.05 Million | 7.76 Million | 37.37 Million |
| Debt repayment | -248.09 Million | -324.22 Million | -428.34 Million | -290 Million | -185 Million | -169.28 Million |
| Dividends payments | -32.39 Million | -51.55 Million | -30.29 Million | -17.1 Million | -29.03 Million | -18.6 Million |
| Common Stock Repurchased | -21.27 Million | - | - | - | 257.65 Million | - |
| Common Stock Issuance | - | - | - | - | 12.34 Million | 34.82 Million |
| Other Financing Activities | -116.59 Million | 491.95 Million | 492.47 Million | 329.16 Million | -48.2 Million | 171.83 Million |
| Accounts receivables | -53.54 Million | -137.05 Million | -37.74 Million | -19.35 Million | -24.65 Million | -84.32 Million |
| Accounts payables | - | 137.05 Million | 37.74 Million | 19.35 Million | 24.65 Million | - |
| Inventory | 4.37 Million | -1.81 Million | -19.01 Million | -12.89 Million | -1.69 Million | 3.28 Million |
| Other working capital | 11.31 Million | -15.51 Million | 264.19 Thousand | -34.41 Million | -55.19 Million | -116.91 Million |
| Cash at beginning of period | 258.59 Million | 188.73 Million | 200.09 Million | 164.95 Million | 187.06 Million | 237.53 Million |
| Cash at end of period | 404.72 Million | 258.59 Million | 188.73 Million | 200.09 Million | 164.95 Million | 187.06 Million |
| Capital Expenditure | -179.73 Million | -236.91 Million | -178.53 Million | -187.95 Million | -127.54 Million | -145.49 Million |
| Effect of forex changes on cash | 4325.27 | 78.46 Thousand | -38.7 Thousand | -248.02 Thousand | -635.42 Thousand | 1.11 Million |
| Net cash flow / Change in cash | 146.12 Million | 69.86 Million | -11.35 Million | 35.14 Million | -22.11 Million | -50.47 Million |
| Free Cash Flow | 85.3 Million | -9.68 Million | 15.35 Million | 11.69 Million | -16.25 Million | -78.97 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 85.94 Million | 21.09 Million | 21.09 Million | 21.87 Million | 21.87 Million | -10.96 Million |
| Depreciation & Amortization | 113.55 Million | 27.6 Million | 27.6 Million | 28.13 Million | 28.13 Million | 114.21 Million |
| Deferred income taxes | - | - | - | -10.05 Million | - | -12.21 Million |
| Stock-based compensation | - | - | - | - | - | 4.41 Million |
| Change in working capital | -37.85 Million | -32.89 Million | -32.89 Million | 8.3 Million | 8.3 Million | -17.32 Million |
| Other non-cash items | 86.64 Million | 59.91 Million | 59.91 Million | -1.52 Million | -1.52 Million | 141.3 Million |
| Investing Cash Flow | -215.01 Million | -47.94 Million | -47.94 Million | -59.56 Million | -59.56 Million | -273.61 Million |
| Investments in PPE | -179.73 Million | -35.94 Million | -35.94 Million | -53.92 Million | -53.92 Million | -236.91 Million |
| Acquisitions | -31.78 Million | -8.05 Million | -8.05 Million | -7.59 Million | -7.59 Million | -53.68 Million |
| Investment purchases | - | - | - | -4.37 Million | - | 0.59 |
| Sales/Maturities of investments | 8.27 Million | - | - | 9.32 Million | - | 1.65 Million |
| Other Investing Activities | -1.19 Million | -3.95 Million | -3.95 Million | 1.95 Million | 1.95 Million | 15.32 Million |
| Financing Cash Flow | 96.1 Million | 43.15 Million | 43.15 Million | 4.89 Million | 4.89 Million | 116.17 Million |
| Debt repayment | -248.09 Million | - | - | -159.93 Million | - | -324.22 Million |
| Dividends payments | -32.39 Million | -5.53 Million | -5.53 Million | -10.66 Million | -10.66 Million | -51.55 Million |
| Common Stock Repurchased | -21.27 Million | -10.63 Million | -10.63 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -116.59 Million | 59.33 Million | 59.33 Million | 15.55 Million | 15.55 Million | 491.95 Million |
| Accounts receivables | -53.54 Million | -33.3 Million | -33.3 Million | 6.52 Million | 6.52 Million | -137.05 Million |
| Accounts payables | - | - | - | -52.59 Million | - | 137.05 Million |
| Inventory | 4.37 Million | 409.57 Thousand | 409.57 Thousand | 1.77 Million | 1.77 Million | -1.81 Million |
| Other working capital | - | - | - | 52.59 Million | - | -15.51 Million |
| Cash at beginning of period | 258.59 Million | 1.00 | 1.00 | 304.36 Million | - | 188.73 Million |
| Cash at end of period | 404.72 Million | 70.92 Million | 70.92 Million | 296.62 Million | 2.13 Million | 258.59 Million |
| Capital Expenditure | -179.73 Million | -35.94 Million | -35.94 Million | -53.92 Million | -53.92 Million | -236.91 Million |
| Effect of forex changes on cash | 4325.27 | -4372.00 | -4372.00 | 6535.00 | 6535.00 | 78.46 Thousand |
| Net cash flow / Change in cash | 146.12 Million | 70.92 Million | 70.92 Million | -7.74 Million | 2.13 Million | 69.86 Million |
| Free Cash Flow | 85.3 Million | 39.77 Million | 39.77 Million | 2.87 Million | 2.87 Million | -9.68 Million |
GCLL
TAU
600057
RDEB
IREN
CULTIBAB